AzTrials
AzTrials

StressSEAPPNCT05617248

Feasibility and Efficacy of a Brief Digital Self-efficacy Training

A study testing Self-efficacy App in people with Stress and Self Efficacy, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study investigates the effects of a digital, scalable self-efficacy training of repeated recall of self-efficacy memories on mental health outcomes, such as self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Stress, Self Efficacy
What is being tested?
Self-efficacy App
Could I receive a placebo?
No, everyone receives an active treatment
How many people
94 participants
Where
1 siteSwitzerland
Study dates
18 May 2020to 9 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • being enrolled at a Swiss university
  • aged between 18 and 29 years
  • experiencing at least moderate stress (score of ≥13 on the Perceived Stress Scale
  • owning a smartphone
  • speaking fluent German

Who cannot join

  • -current psychiatric disorder

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Birgit Kleim

    Zurich, Select..., 8008

Other trials in Switzerland

About this study

Official title: Feasibility and Efficacy of a Brief Digital Self-efficacy Training in University Students With Self-reported Elevated Stress: A Randomized Controlled Trial

The study investigates the effects of a digital, scalable self-efficacy training of repeated recall of self-efficacy memories on mental health outcomes, such as self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes. A total of 94 students with elevated stress levels (≤ 13 on the Perceived Stress Scale) will be recruited and randomly assigned to training and control group. Individuals will either engage in the self-efficacy training app combined with Ecological Momentary Assessment (EMA) for 1 week (training group) or in EMA only for 1 week (control group). Baseline and post assessments will measure changes in self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes.

Read the detailed description

Self-efficacy is associated with positive mental health outcomes and has been proposed as a putative contributor to therapeutic outcomes in the treatment of mental health problems. It can be enhanced through experimental inductions and the recall of autobiographical mastery experiences, which have mostly been conducted in person and in the laboratory until today.

The study will investigate effects of a digital, scalable self-efficacy training of repeated recall of self-efficacy memories on mental health outcomes, such as self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes. The study will recruit 94 students with elevated stress levels (≤ 13 on the Perceived Stress Scale) and randomly assigned them to training and control group. Individuals will either engage in the self-efficacy training app combined with Ecological Momentary Assessment (EMA) for 1 week (training group) or in EMA only for 1 week (control group). Baseline and post assessments will measure changes in self-efficacy, anxiety, stress, hopelessness, and other mental health outcomes.

Being tested
Self-efficacy App
Keywords
self-efficacy, stress, digital, intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-efficacy AppBehavioural

    The training starts with a psychoeducational video and instructions to define two autobiographical self-efficacy The individuals will then receive three self-efficacy trainings per day based on their autobiographical memories and combined with a slow breathing exercise. Additionally, they will receive 10 daily EMA questionnaires on mood, social contacts, and virtual context.

Study groups in NCT05617248
Study groupRoleWhat they receive
Experimental: Self-efficacy training (App)ExperimentalThis group will receive a digital one week self-efficacy training with three training sessions per day and EMA (10 per day).
Receives: Behavioral: Self-efficacy App
ControlNo interventionThis group will receive EMA questionnaires for one week (10 per day).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. General self-efficacy

    The General Self-Efficacy Scale (Schwarzer \& Jerusalem, 1995; Tipton \& Worthington, 1984) will measure the general self-efficacy.

    Measured: change from baseline to 1 day post intervention; time frame: 1 week

Secondary outcomes (6)
  1. Perceived stress

    The Perceived Stress Scale (Cohen, Kamarck, \& Mermelstein, 1983; Klein et al., 2016) will measure perceived stress.

    Measured: change from screening to 1 day post intervention; time frame: 1 week

  2. Positive and negative affect

    change from baseline to 1 day post intervention; time frame: 1 week

    Measured: The Positive and Negative Affect Scale (Krohne, Egloff, Kohlmann, & Tausch, 1996; Watson, Clark, & Tellegen, 1988) will measure positive and negative affect.

  3. Hope

    The Trait Hope Scale (Krause, 2002; Snyder et al., 1991) will measure hope.

    Measured: change from baseline to 1 day post intervention; time frame: 1 week

  4. Depression

    change from baseline to 1 day post intervention; time frame: 1 week

    Measured: The Beck Depression Inventory-II (Beck, Steer, Ball, & Ranieri, 1996; Kuhner, Burger, Keller, & Hautzinger, 2007) will measure depression.

  5. Anxiety

    State-Trait Anxiety Inventory (Laux, Glanzmann, Schaffner, \& Spielberger, 1981; Spielberger, Gorsuch, Lushene, Gagg, \& Jacobs, 1983) will measure state and trait anxiety.

    Measured: change from baseline to 1 day post intervention; time frame: 1 week

  6. Hopelessness

    The Beck Hopelessness Scale (Beck, Weissman, Lester, \& Trexler, 1974; Kliem, Lohmann, Mossle, \& Brahler, 2018) will measure hopelessness.

    Measured: change from baseline to 1 day post intervention; time frame: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2022
  2. Study start18 May 2020
  3. Primary completion9 Nov 2020
  4. Study completion9 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial testing a brief digital intervention (SeApp) against a control group receiving only EMA
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
94 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05617248
Sponsor's protocol ID
SEAPPUZH
Acronym
SEAPP
Status last verified
Nov 2022
First submitted
12 Sep 2022
Last updated
15 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: It is planned to make the anonymised data available on a public repository.

Publications

  • Rohde J, Marciniak MA, Henninger M, Homan S, Ries A, Paersch C, Friedman O, Brown AD, Kleim B. Effects of a digital self-efficacy training in stressed university students: A randomized controlled trial. PLoS One. 2024 Oct 31;19(10):e0305103. doi: 10.1371/journal.pone.0305103. eCollection 2024.

    PubMed 39480821
  • Rohde J, Marciniak MA, Henninger M, Homan S, Paersch C, Egger ST, Seifritz E, Brown AD, Kleim B. Investigating Relationships Among Self-Efficacy, Mood, and Anxiety Using Digital Technologies: Randomized Controlled Trial. JMIR Form Res. 2023 Aug 14;7:e45749. doi: 10.2196/45749.

    PubMed 37578827

Questions about this trial

What is this clinical trial studying?

A study testing Self-efficacy App in people with Stress and Self Efficacy, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

General self-efficacy (time frame: change from baseline to 1 day post intervention; time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05617248, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in